Palga Science Award

Voor wie is de award bedoeld?

De Palga Science Award staat open voor onderzoekers die gebruikmaken van de Palga-databank in hun wetenschappelijke werk. Dit kunnen zowel jonge onderzoekers als ervaren wetenschappers zijn, zolang hun onderzoek een substantiële bijdrage levert aan de pathologie en de bredere gezondheidszorg.

Selectieprocedure

Onderzoekers kunnen deelnemen door een abstract in te dienen waarin hun onderzoek wordt toegelicht. Een onafhankelijke jury, bestaande uit experts uit de pathologie en data-gedreven zorg, beoordeelt de inzendingen op basis van innovatie, wetenschappelijke kwaliteit en maatschappelijke impact.

Op basis van deze beoordeling worden drie genomineerden geselecteerd. Hun abstracts worden gepubliceerd op deze website en krijgen extra aandacht tijdens de Pathologendagen.

Uitreiking van de award

Tijdens de Pathologendagen presenteren de drie genomineerden hun onderzoek aan het publiek. De jury kiest vervolgens de winnaar, die de Palga Science Award in ontvangst mag nemen. Naast erkenning ontvangt de winnaar een geldbedrag als stimulans voor verder onderzoek.

Bekijk alle inzendingen in 2025 (willekeurige volgorde)

1. Diagnosis of patients with fibrolamellar carcinoma: a Dutch nationwide study
2. The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study
3. Lower degree of microsatellite instability in colorectal carcinomas from MSH6-associated Lynch syndrome patients
4. Notification of locoregional breast cancer recurrence based on pathology reports: a nationwide validation study with the Netherlands Cancer Registry
5. Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue
6. Placental lesions and key obstetric outcomes: a unique linked cohort study using PALGA national pathology and Perined pregnancy registries
7. The incidence of Castleman disease in The Netherlands: a retrospective study based on Dutch pathology reports
8. Nationwide Implementation and Evaluation of the Tumor-First Workflow for Genetic Testing in Ovarian Carcinoma
9. Leveraging Sequence-to-Sequence Models for Semantic Annotation of Dutch Pathology Reports
10. Artificial intelligence-based pRb subtyping of pulmonary large cell neuroendocrine carcinoma on small haematoxylin and eosin-stained specimens
11. OTP, CD44, and Ki-67: A prognostic marker panel for relapse free survival in patients with surgically resected pulmonary carcinoid
12. Identification of defined molecular subgroups based on immunohistochemical analyses and potential therapeutic vulnerabilities of pulmonary carcinoids
13. Combining PALGA and IKNL data to create a representative cohort for validating LY75 promoter methylation as a predictor of stage I–III melanoma patients at high risk of disease recurrence
14. Tumor-positive peritoneal cytology in patients with gastric cancer is associated with poor outcome: A nationwide study
15. Outcomes of endometrial cancer preven3on strategies in patients with Lynch syndrome: a nationwide cohort study in the Netherlands
16. Prevalence and Impact of Vulvar Lesions Diagnosed Prior to Vulvar Squamous Cell Carcinoma: A Population-Based Cohort Study
17. Using real-world data for machine-learning algorithms to predict the treatment response in advanced melanoma: a pilot study for personalizing cancer care
18. Outcomes of cervical cancer screening among women with HIV in the Netherlands
19. The prevalence and clinical relevance of cervical abnormalities after an amputation of the cervix as part of prolapse surgery: a cross-sectional study
20. The Dutch Early-Stage Melanoma Study (D-ESMEL): a Discovery Set and Validation Cohort to Predict the Absolute Risk of Distant Metastases in Stage I/II Cutaneous Melanoma
21. Incidence of cervical intraepithelial neoplasia and cervical cancer in transmasculine and gender diverse individuals using testosterone: a retrospective, single centre cohort study
22. A large language model based approach for extraction of molecular biomarker information from pathology reports: a nationwide study of EGFR and KRAS testing rates in patients with lung cancer in the Netherlands
23. Ductal Carcinoma In Situ of the breast: Potential to metastasize? A nationwide cancer registry-based study
24. Trends in liver resections over the past 30 years in The Netherlands
25. Prediction models are helpful for patients with a biopsy diagnosis of ductal carcinoma in situ
26. The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: a nationwide analysis
27. Early salpingectomy with delayed oophorectomy as alternative for risk-reducing salpingo-oophorectomy – the first 2000 participants in the ongoing international TUBA-WISP II study
28. Development and Validation of a Transcriptomic Classifier for Predicting Invasive Breast Cancer Risk in Ductal Carcinoma In Situ
29. Histopathologic Findings of Gynaecologic Tissue in Transmasculine and Gender Diverse individuals Using Testosterone: a Nationwide Cohort Study
30. Increased skin autofluorescence predicts future cancer development
31. High risk of colorectal cancer after high-grade dysplasia in inflammatory bowel disease patients
32. 10-year survival after resection of pancreatic ductal adenocarcinoma with pathological re-examination in a nationwide cohort
33. Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer
34. Expanding histopathological assessment provides limited prognostic value for metastatic cutaneous squamous cell carcinoma: insights from two nested case-control studies
35. Enabling Molecular Subtyping in DCIS: Leveraging Foundation Models for Robust Biomarker Scoring and Patient Stratification
36. Critical evaluation of sentinel lymph node biopsy in pT1b and pT2a melanoma: a nationwide population-based study
37. Deep Learning for Predicting Invasive Recurrence of Ductal Carcinoma In Situ of the breast: Leveraging Histopathology Images and Clinical Features
38. Loss to follow up after cervical intraepithelial neoplasia after referral to the general practitioner

Benieuwd naar eerdere inzendingen? Nog even geduld, we werken aan een dropdown menu.

Meer informatie & deelname

Wil je meer weten over de Palga Science Award of zelf deelnemen? Houd deze pagina in de gaten voor de volgende ronde van inschrijvingen of neem contact met ons op via stichting@palga.nl.